Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2000
11/02/2000WO2000065060A2 Dna sequence and recombinant production of a graminae allergen
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065052A1 Bridge-1, a transcription factor
11/02/2000WO2000065047A1 Tumor suppressor genes
11/02/2000WO2000065043A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
11/02/2000WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
11/02/2000WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000WO2000064957A2 Differentially acting op detoxifying sponges
11/02/2000WO2000064954A1 Polymeric encapsulation system promoting angiogenesis
11/02/2000WO2000064945A1 Inhibition of endopeptidase by cystatins
11/02/2000WO2000064944A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000WO2000064941A2 G-protein coupled receptor and method of using same
11/02/2000WO2000064940A1 Insulin crystals for pulmonary administration
11/02/2000WO2000064939A2 Peptides derived from vasostatin i and the use thereof as anti-fungal agents
11/02/2000WO2000064938A2 Peptide homodimers or peptide heterodimers derived from interleukin 12
11/02/2000WO2000064937A1 Inactivated cytokines for immunisation
11/02/2000WO2000064936A2 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2
11/02/2000WO2000064935A1 A novel serotonin-gated anion channel
11/02/2000WO2000064934A1 Therapeutic compositions and methods for treating tumors
11/02/2000WO2000064933A1 Transcriptional activation inhibitory protein
11/02/2000WO2000064932A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
11/02/2000WO2000064931A1 A ligand of the protein 'beacon'
11/02/2000WO2000064930A2 Tribonectins
11/02/2000WO2000064929A1 Membrane disruptive peptides covalently oligomerized
11/02/2000WO2000064927A1 Cyclic hexapeptides having antibiotic activity
11/02/2000WO2000064926A1 Melanocyte-stimulating hormone inhibitors
11/02/2000WO2000064925A1 Method of inhibiting leukocyte adhesion to fibrinogen
11/02/2000WO2000064920A1 Compositions, methods, and kits relating to resistin
11/02/2000WO2000064919A1 Compositions, methods, and kits relating to the tig-1 gene, a novel tzd inducible gene
11/02/2000WO2000064864A1 N-protected amines and their use as prodrugs
11/02/2000WO2000064863A1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
11/02/2000WO2000064488A2 Somatic transgene immunization and related methods
11/02/2000WO2000064485A2 Specifically targeted catalytic antagonists and uses thereof
11/02/2000WO2000064484A2 Conjugate having a cleavable linkage for use in a liposome
11/02/2000WO2000064483A2 Releasable linkage and compositions containing same
11/02/2000WO2000064482A1 Nerve cell growth modulators (amphibodies)
11/02/2000WO2000064481A1 Controlled release of growth factors from heparin containing matrices
11/02/2000WO2000064479A1 Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders
11/02/2000WO2000064475A1 Treatment of metastatic cancer through mts-1 gene
11/02/2000WO2000064473A1 Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins
11/02/2000WO2000064471A1 Model membrane systems
11/02/2000WO2000064470A1 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
11/02/2000WO2000064469A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
11/02/2000WO2000064468A2 Therapeutic compositions and methods for enhancing angiogenesis
11/02/2000WO2000064467A1 Inhibition of proteasome function induces programmed cell death in endothelial cells
11/02/2000WO2000064466A1 Localization of major peptide autoepitopes for nucleosome specific t cells of systemic lupus erythematosus
11/02/2000WO2000064465A1 Death domain containing receptors
11/02/2000WO2000064464A1 NUCLEIC ACIDS AND PROTEINS OF A RAT GANGLIOSIDE GM1-SPECIFIC αl→2FUCOSYLTRANSFERASE AND USES THEREOF
11/02/2000WO2000064460A2 Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin
11/02/2000WO2000064456A2 Substitution infusion fluid and citrate anticoagulation
11/02/2000WO2000064455A1 Method of enhancing the efficacy of anti-tumor agents
11/02/2000WO2000064436A1 Methods of delivery of cetyl myristoleate
11/02/2000WO2000064400A2 Methods for treating congestive heart failure
11/02/2000WO2000064262A1 Antisense human fucosyltransferase sequences and methods of use thereof
11/02/2000WO2000064261A1 Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof
11/02/2000WO2000064260A1 Compositions and methods for treatment of hyperproliferative diseases
11/02/2000WO2000044394A8 Method of producing elastin, elastin-based materials and tropoelastin materials
11/02/2000WO2000043514A3 Human acid sensing ion channel and uses thereof
11/02/2000WO2000043493A8 Metalloproteinase adam 22
11/02/2000WO2000042982A8 Methods and kits for removing, treating, or preventing lice with driable pediculostatic agents
11/02/2000WO2000041539A3 Human beta-1,3-galactosyltransferase homolog, znssp6
11/02/2000WO2000041508A3 Combination therapy of cancer by the activation of co-stimulatory molecules expressed by immune cells and cytokines
11/02/2000WO2000040723A3 Methods and products for delivering nucleic acids
11/02/2000WO2000040272A3 P450 / acetaminophen gdept for cancer treatment
11/02/2000WO2000040271A3 P450 / acetaminophen gdept for cancer treatment
11/02/2000WO2000039299A3 Streptococcus antigens
11/02/2000WO2000039136A3 Human brainiac-5
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000WO2000038626A3 Substrate composition and method of use for sequestration of skin irritants
11/02/2000WO2000037642A9 Method of enhancing the biological activity of ligands
11/02/2000WO2000037640A9 Compositions and methods for the treatment of tumor
11/02/2000WO2000037093A8 Bone resorption inhibitors
11/02/2000WO2000035408A3 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
11/02/2000WO2000033863A3 Therapeutic agent for the suppression of snoring noises
11/02/2000WO2000029029A9 Compositions and methods for producing vascular occlusion
11/02/2000WO2000018932A3 Receptor based antagonists and methods of making and using
11/02/2000WO2000018917A3 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION
11/02/2000WO2000008173A9 Identification and functional characterization of a novel ribosomal s6 protein kinase
11/02/2000WO2000004926A3 Conjugates for treating inflammatory disorders and associated tissue damage
11/02/2000EP1048734A2 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
11/02/2000EP1048728A1 Means and method for the prevention and or treatment of trypanosomosis
11/02/2000EP1048727A1 Gene encoding novel transmembrane protein
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000EP1048307A2 Dialysis membrane for the preparation of hematopoietic inhibiting factor containing compositions
11/02/2000EP1048301A1 Sustained release compositions, process for producing the same and utilization thereof
11/02/2000EP1047792A1 A method for depopulating of vertebrate testis and for generation of transgenic species
11/02/2000EP1047788A2 Metastatic breast and colon cancer regulated genes
11/02/2000EP1047787A1 Human calcineurin b-like protein
11/02/2000EP1047786A2 Nucleic acid corresponding to mutation associated with cholestasis syndromes
11/02/2000EP1047784A2 Neissera meningitidis antigens
11/02/2000EP1047782A1 Interleukin-1 receptor antagonist beta (il-1ra beta)
11/02/2000EP1047781A1 Il-18 receptors
11/02/2000EP1047780A1 Orphan receptors
11/02/2000EP1047779A2 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system
11/02/2000EP1047776A2 Therapeutic composition comprising the kal protein and use of the kal protein
11/02/2000EP1047775A1 Hematopoietic signaling factor
11/02/2000EP1047774A1 Methods and compositions for gene delivery
11/02/2000EP1047773A1 Cubilin protein, dna sequences encoding cubilin and uses thereof
11/02/2000EP1047772A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047770A1 Histidine kinase
1 ... 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 ... 3163